Skip to main content
Fig. 1 | AIDS Research and Therapy

Fig. 1

From: Changing trends in lipid profile and biomarkers of renal function and bone metabolism before and after switching from tenofovir disoproxil fumarate to tenofovir alafenamide: a prospective observational study

Fig. 1

Rate of change in biomarkers before and after switching from tenofovir disoproxil to tenofovir alafenamide. Vertical axis represents the rate of change (%) of each biomarker compared to the baseline (before switching antiretrovirals). a Rate of change in urine-liver-type fatty acid binding protein/creatinine (L-FABP/Cr) levels. b Rate of change in low-density lipoprotein cholesterol (LDL-C) levels. c Rate of change in urine-N-terminal telopeptide/creatinine (U-NTx/Cr) levels. d Rate of change in bone-specific alkaline phosphatase (BAP) levels. e Percentage of detection of proteinuria

Back to article page

AIDS Research and Therapy

ISSN: 1742-6405

Contact us